|
1
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamasaki M, Miyata H, Miyazaki Y,
Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M and Doki
Y: Perioperative therapy for esophageal cancer. Gen Thorac
Cardiovasc Surg. 62:531–540. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fesler A, Zhai H and Ju J: miR-129 as a
novel therapeutic target and biomarker in gastrointestinal cancer.
Onco Targets Ther. 7:1481–1485. 2014.PubMed/NCBI
|
|
4
|
Võsa U, Vooder T, Kolde R, Fischer K, Välk
K, Tõnisson N, Roosipuu R, Vilo J, Metspalu A and Annilo T:
Identification of miR-374a as a prognostic marker for survival in
patients with early-stage nonsmall cell lung cancer. Genes
Chromosomes Cancer. 50:812–822. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen X, Gong J, Zeng H, Chen N, Huang R,
Huang Y, Nie L, Xu M, Xia J, Zhao F, et al: MicroRNA145 targets
BNIP3 and suppresses prostate cancer progression. Cancer Res.
70:2728–2738. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu D, Pan H, Zhou Y, Zhou J, Fan Y and Qu
P: microRNA-133b downregulation and inhibition of cell
proliferation, migration and invasion by targeting matrix
metallopeptidase-9 in renal cell carcinoma. Mol Med Rep.
9:2491–2498. 2014.PubMed/NCBI
|
|
7
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
|
8
|
Pineau P, Volinia S, McJunkin K, Marchio
A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM and
Dejean A: miR-221 overexpression contributes to liver
tumorigenesis. Proc Natl Acad Sci USA. 107:264–269. 2010.
View Article : Google Scholar :
|
|
9
|
Huang J, Zhang SY, Gao YM, Liu YF, Liu YB,
Zhao ZG and Yang K: MicroRNAs as oncogenes or tumour suppressors in
oesophageal cancer: Potential biomarkers and therapeutic targets.
Cell Prolif. 47:277–286. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li J, Shan F, Xiong G, Wang JM, Wang WL,
Xu X and Bai Y: Transcriptional regulation of miR-146b by C/EBPβ
LAP2 in esophageal cancer cells. Biochem Biophys Res Commun.
446:267–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng X, Wang Y, Ma Z, Yang R, Liang S,
Zhang M, Song S, Li S, Liu G, Fan D, et al: MicroRNA-645,
up-regulated in human adencarcinoma of gastric esophageal junction,
inhibits apoptosis by targeting tumor suppressor IFIT2. BMC Cancer.
14:6332014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang N, Fu H, Song L, Ding Y, Wang X,
Zhao C and Zhao Y, Jiao F and Zhao Y: MicroRNA-100 promotes
migration and invasion through mammalian target of rapamycin in
esophageal squamous cell carcinoma. Oncol Rep. 32:1409–1418.
2014.PubMed/NCBI
|
|
13
|
Wang TY, Liu SG, Zhao BS, Qi B, Qin XG and
Yao WJ: Implications of microRNA-197 downregulated expression in
esophageal cancer with poor prognosis. Genet Mol Res. 13:5574–5581.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang M, Yang Q, Zhang L, Zhou S, Ye W,
Yao Q, Li Z, Huang C, Wen Q and Wang J: miR-302b is a potential
molecular marker of esophageal squamous cell carcinoma and
functions as a tumor suppressor by targeting ErbB4. J Exp Clin
Cancer Res. 33:102014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang Y, Chuang A, Hao H, Talbot C, Sen T,
Trink B, Sidransky D and Ratovitski E: Phospho-ΔNp63α is a key
regulator of the cisplatin-induced microRNAome in cancer cells.
Cell Death Differ. 18:1220–1230. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang W, Corrigan-Cummins M, Hudson J,
Maric I, Simakova O, Neelapu SS, Kwak LW, Janik JE, Gause B, Jaffe
ES, et al: MicroRNA profiling of follicular lymphoma identifies
microRNAs related to cell proliferation and tumor response.
Haematologica. 97:586–594. 2012. View Article : Google Scholar :
|
|
17
|
Namløs HM, Meza-Zepeda LA, Barøy T,
Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H,
Cleton-Jansen AM and Myklebost O: Modulation of the osteosarcoma
expression phenotype by microRNAs. PLoS One. 7:e480862012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang ZC, Huang Y, Wang XJ, Wang M and Ma
LL: Expression of circulating microRNAs in patients with bladder
urothelial carcinoma. Beijing Da Xue Xue Bao. 45:532–536. 2013.In
Chinese. PubMed/NCBI
|
|
19
|
Wang Y, Xia H, Zhuang Z, Miao L, Chen X
and Cai H: Axl-altered microRNAs regulate tumorigenicity and
gefitinib resistance in lung cancer. Cell Death Dis. 5:e12272014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu D, Li L, Yang Y, Liu W and Wu J: The
Axin2 rs2240308 polymorphism and susceptibility to lung cancer in a
Chinese population. Tumour Biol. 35:10987–10991. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hu J, Fang Y, Cao Y, Qin R and Chen Q:
miR-449a regulates proliferation and chemosensitivity to cisplatin
by targeting cyclin D1 and BCL2 in SGC7901 cells. Dig Dis Sci.
59:336–345. 2014. View Article : Google Scholar
|
|
22
|
Li H, Zheng D, Zhang B, Liu L, Ou J, Chen
W, Xiong S, Gu Y and Yang J: mir-208 promotes cell proliferation by
repressing SOX6 expression in human esophageal squamous cell
carcinoma. J Transl Med. 12:1962014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Wang J, Wang Y, Fu Q, Lei YH, Nie
ZY, Qiu J and Bao TY: Protective effect of exogenous matrix
metalloproteinase-9 on chronic renal failure. Exp Ther Med.
7:329–334. 2014.PubMed/NCBI
|
|
24
|
Ma C, Liu C, Huang P, Kaku H, Chen J, Guo
K, Ueki H, Sakai A, Nasu Y, Kumon H, et al: Significant association
between the Axin2 rs2240308 single nucleotide polymorphism and the
incidence of prostate cancer. Oncol Lett. 8:789–794.
2014.PubMed/NCBI
|
|
25
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA
expression profiles of esophageal cancer. J Thorac Cardiovasc Surg.
135:255–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kimura S, Naganuma S, Susuki D, Hirono Y,
Yamaguchi A, Fujieda S, Sano K and Itoh H: Expression of microRNAs
in squamous cell carcinoma of human head and neck and the
esophagus: miR-205 and miR-21 are specific markers for HNSCC and
ESCC. Oncol Rep. 23:1625–1633. 2010.PubMed/NCBI
|
|
27
|
Matsushima K, Isomoto H, Kohno S and Nakao
K: MicroRNAs and esophageal squamous cell carcinoma. Digestion.
82:138–144. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang C, Wang C, Chen X, Yang C, Li K,
Wang J, Dai J, Hu Z, Zhou X, Chen L, et al: Expression profile of
microRNAs in serum: A fingerprint for esophageal squamous cell
carcinoma. Clin Chem. 56:1871–1879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park S, Yun E, Hwang IH, Yoon S, Kim DE,
Kim JS, Na M, Song GY and Oh S: Ilimaquinone and ethylsmenoquinone,
marine sponge metabolites, suppress the proliferation of multiple
myeloma cells by down-regulating the level of β-catenin. Mar Drugs.
12:3231–3244. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li AF, Hsu PK, Tzao C, Wang YC, Hung IC,
Huang MH and Hsu HS: Reduced axin protein expression is associated
with a poor prognosis in patients with squamous cell carcinoma of
esophagus. Ann Surg Oncol. 16:2486–2493. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakajima M, Fukuchi M, Miyazaki T, Masuda
N, Kato H and Kuwano H: Reduced expression of Axin correlates with
tumour progression of oesophageal squamous cell carcinoma. Br J
Cancer. 88:1734–1739. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao Y, Song C, Hui L, Li CY, Wang J, Tian
Y, Han X, Chen Y, Tian DL, Qiu X, et al: Overexpression of RNF146
in non-small cell lung cancer enhances proliferation and invasion
of tumors through the Wnt/β-catenin signaling pathway. PLoS One.
9:e853772014. View Article : Google Scholar
|
|
33
|
Tetsu O and McCormick F: Beta-catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
